Korean Cancer Patients’ Awareness of Clinical Trials, Perceptions on the Benefit and Willingness to Participate
2
조회
0
다운로드
2
인용
0
참고문헌
키워드
초록
Purpose The purpose of this study was to assess current levels of awareness of clinical trials (CTs), perceptions regarding their benefits and willingness to participate to CTs among Korean cancer patients. Materials and Methods From December 2012 to August 2015, we distributed questionnaires to cancer patients receiving systemic anti-cancer therapy at Seoul National University Hospital, Seoul, Korea. Results A total of 397 out of 520 requested patients (76.3%) responded to the survey. Among the 397 patients, 62.5% were female and the median age was 52 years. Overall, 97.4% (387/397) answered that they have at least heard of CTs. When asked about their level of awareness, 23.8% (92/387) answered that they could more than roughly explain about CTs. The average visual analogue scale score of CT benefit in all patients was 6.43 (standard deviation, 2.20). Patients who were only familiar with the term without detailed knowledge of the contents had the least expectation of benefit from CTs (p=0.015). When asked about their willingness to participate in CTs, 56.7% (225/397) answered positively. Patients with higher levels of awareness of CTs showed higher willingness to participate (p < 0.001). Heavily treated patients and patients with previous experience regarding CTs also showed a higher willingness to participate (p < 0.001). The perceived benefit of CTs was higher in the group willing to participate (p=0.026). Conclusion The patient’s level of awareness regarding CTs was positively related to the positive perception and willingness to participate. Although the general awareness of CTs was high, a relatively large proportion of patients did not have accurate knowledge; therefore, proper and accurate patient education is necessary.
Abstract
Purpose The purpose of this study was to assess current levels of awareness of clinical trials (CTs), perceptions regarding their benefits and willingness to participate to CTs among Korean cancer patients. Materials and Methods From December 2012 to August 2015, we distributed questionnaires to cancer patients receiving systemic anti-cancer therapy at Seoul National University Hospital, Seoul, Korea. Results A total of 397 out of 520 requested patients (76.3%) responded to the survey. Among the 397 patients, 62.5% were female and the median age was 52 years. Overall, 97.4% (387/397) answered that they have at least heard of CTs. When asked about their level of awareness, 23.8% (92/387) answered that they could more than roughly explain about CTs. The average visual analogue scale score of CT benefit in all patients was 6.43 (standard deviation, 2.20). Patients who were only familiar with the term without detailed knowledge of the contents had the least expectation of benefit from CTs (p=0.015). When asked about their willingness to participate in CTs, 56.7% (225/397) answered positively. Patients with higher levels of awareness of CTs showed higher willingness to participate (p < 0.001). Heavily treated patients and patients with previous experience regarding CTs also showed a higher willingness to participate (p < 0.001). The perceived benefit of CTs was higher in the group willing to participate (p=0.026). Conclusion The patient’s level of awareness regarding CTs was positively related to the positive perception and willingness to participate. Although the general awareness of CTs was high, a relatively large proportion of patients did not have accurate knowledge; therefore, proper and accurate patient education is necessary.
참고문헌 (20)
- "FDA approved drugs for oncology" (2016)[URL]
- "Trends, charts, and maps" (2016)[URL]
- Caldwell PH, "Strategies for increasing recruitment to randomised controlled trials: systematic review", PLoS Med, 7, pp.e1000368~ (2010)
- Ross S, "Barriers to participation in randomised controlled trials : a systematic review", J Clin Epidemiol, 52, pp.1143~1156 (1999)
- Ford JG, "Barriers to recruiting underrepresented populations to cancer clinical trials : a systematic review", Cancer, 112, pp.228~242 (2008)
- Kim JW, "Cancer patients' awareness of clinical trials, perceptions on the benefit and willingness to participate : Korean perspectives", Br J Cancer, 99, pp.1593~1599 (2008)
- "South Korea GDP" (2016)[URL]
- 심병용, "Current Status and Challenges of Cancer Clinical Trials in Korea", Cancer Research and Treatment, 48(1), pp.20~27 (2016), 대한암학회[DOI]
- Tejeda HA, "Representation of African-Americans, Hispanics, and whites in National Cancer Institute cancer treatment trials", J Natl Cancer Inst, 88, pp.812~816 (1996)
- Lovato LC, "Recruitment for controlled clinical trials : literature summary and annotated bibliography", Control Clin Trials, 18, pp.328~352 (1997)
- Haidich AB, "Effect of early patient enrollment on the time to completion and publication of randomized controlled trials", Am J Epidemiol, 154, pp.873~880 (2001)
- Ehrlich PF, "Lessons learned from a failed multi-institutional randomized controlled study", J Pediatr Surg, 37, pp.431~436 (2002)
- Comis RL, "Public attitudes toward participation in cancer clinical trials", J Clin Oncol, 21, pp.830~835 (2003)
- Sood A, "Patients' attitudes and preferences about participation and recruitment strategies in clinical trials", Mayo Clin Proc, 84, pp.243~247 (2009)
- Wallington SF, "Assessing the awareness of and willingness to participate in cancer clinical trials among immigrant Latinos", J Community Health, 37, pp.335~343 (2012)
- Li JY, "Participation in cancer clinical trials as viewed by Chinese patients and their families", Oncology, 79, pp.343~348 (2010)
- Bazarbashi S, "Awareness and perceptions of clinical trials in cancer patients and their families in Saudi Arabia", J Cancer Educ, 30, pp.655~659 (2015)
- Lara PN Jr, "Evaluation of factors affecting awareness of and willingness to participate in cancer clinical trials", J Clin Oncol, 23, pp.9282~9289 (2005)
- Lee SJ, "Unique perception of clinical trials by Korean cancer patients", BMC Cancer, 12, pp.594~ (2012)
- Denicoff AM, "The National Cancer Institute-American Society of Clinical Oncology Cancer Trial Accrual Symposium : summary and recommendations", J Oncol Pract, 9, pp.267~276 (2013)